Phase I and pharmacological study of the oral farnesyltransferase inhibitor SCH 66336 given once daily to patients with advanced solid tumours.

A Awada; Ferry Eskens; M Piccart; DL Cutler; Ate van der Gaast; H Bleiberg; J Wanders; MN Faber; P Statkevich; P Fumoleau; Jaap Verweij

doi:10.1016/S0959-8049(02)00379-9

Phase I and pharmacological study of the oral farnesyltransferase inhibitor SCH 66336 given once daily to patients with advanced solid tumours.

A Awada
, Ferry Eskens
, M Piccart
, DL Cutler
, Ate van der Gaast
, H Bleiberg
, J Wanders
, MN Faber
, P Statkevich
, P Fumoleau
, Jaap Verweij

Medical Oncology

Research output: Contribution to journal › Article › Academic › peer-review

59 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	2272-2278
Number of pages	7
Journal	European Journal of Cancer
Volume	38
DOIs	https://doi.org/10.1016/S0959-8049(02)00379-9
Publication status	Published - 2002

Research programs

EMC MM-03-86-08

Access to Document

10.1016/S0959-8049(02)00379-9

http://hdl.handle.net/1765/72584

Cite this

Awada, A., Eskens, F., Piccart, M., Cutler, DL., van der Gaast, A., Bleiberg, H., Wanders, J., Faber, MN., Statkevich, P., Fumoleau, P., & Verweij, J. (2002). Phase I and pharmacological study of the oral farnesyltransferase inhibitor SCH 66336 given once daily to patients with advanced solid tumours. European Journal of Cancer, 38, 2272-2278. https://doi.org/10.1016/S0959-8049(02)00379-9

@article{d808d938a3364876866b2fa9cc30aed6,

title = "Phase I and pharmacological study of the oral farnesyltransferase inhibitor SCH 66336 given once daily to patients with advanced solid tumours.",

author = "A Awada and Ferry Eskens and M Piccart and DL Cutler and \{van der Gaast\}, Ate and H Bleiberg and J Wanders and MN Faber and P Statkevich and P Fumoleau and Jaap Verweij",

year = "2002",

doi = "10.1016/S0959-8049(02)00379-9",

language = "Undefined/Unknown",

volume = "38",

pages = "2272--2278",

journal = "European Journal of Cancer",

issn = "0959-8049",

publisher = "Elsevier Ltd.",

}

Awada, A, Eskens, F, Piccart, M, Cutler, DL, van der Gaast, A, Bleiberg, H, Wanders, J, Faber, MN, Statkevich, P, Fumoleau, P & Verweij, J 2002, 'Phase I and pharmacological study of the oral farnesyltransferase inhibitor SCH 66336 given once daily to patients with advanced solid tumours.', European Journal of Cancer, vol. 38, pp. 2272-2278. https://doi.org/10.1016/S0959-8049(02)00379-9

TY - JOUR

T1 - Phase I and pharmacological study of the oral farnesyltransferase inhibitor SCH 66336 given once daily to patients with advanced solid tumours.

AU - Awada, A

AU - Eskens, Ferry

AU - Piccart, M

AU - Cutler, DL

AU - van der Gaast, Ate

AU - Bleiberg, H

AU - Wanders, J

AU - Faber, MN

AU - Statkevich, P

AU - Fumoleau, P

AU - Verweij, Jaap

PY - 2002

Y1 - 2002

U2 - 10.1016/S0959-8049(02)00379-9

DO - 10.1016/S0959-8049(02)00379-9

M3 - Article

SN - 0959-8049

VL - 38

SP - 2272

EP - 2278

JO - European Journal of Cancer

JF - European Journal of Cancer

ER -